Global regenerative medicine market was valued at USD 27.29 Billion in 2020. It is expected to increase at a compound annual rate (CAGR of 11.27%) between 2021 and 2027. Tissue Engineering is the segment expected to see the greatest growth in the Global Regenerative Medicine Market. Biomaterials currently hold the largest market share in global regenerative medicine.
Regenerative medicine has the potential to treat chronic, incurable diseases such as Alzheimer’s disease, Parkinson’s disease, diabetes, and other conditions. The Alliance for Regenerative Medicine estimates that around 1,028 clinical trials in regenerative medicine are currently underway. In 2018, regenerative medicine was funded with a total of USD 13.3 billion in global financing. The forecast period will see a significant increase in investment by market leaders in research and development of regenerative medicines.
Driving Factors
Growing prevalence of chronic diseases, genetic disorders, and cancer
Over the past few decades, the prevalence and incidence of chronic diseases like CVD, cancer and diabetes has increased dramatically around the world. Diabetes and obesity can lead to an increase in the number and complexity of wounds like infections, ulcerations (leg and foot ulcers), as well as surgical wounds. These will need treatment and may result in exorbitant medical costs.
Ask For PDF Sample Report Here: https://market.us/report/regenerative-medicine-market/request-sample/
Restraining Factors
High cost of cell and gene therapies
The cell and gene therapies represent significant medical and scientific advancements for patients with serious and terminal illnesses. These therapies are changing the way diseases are treated and could even be cured. Injectable therapies will enable doctors and other medical professionals to infuse cells/genes through injectable methods, thereby avoiding multiple surgeries and the need for a number of drugs. Although these therapies can be life-saving and more effective than traditional treatments, demand is lower than anticipated. This is due to the high cost of these therapies as well as difficulties in obtaining coverage and reimbursements for them.
Market Key Trends
- The report provides an in-depth assessment of the regenerative medicines market and future forecasts. It also identifies potential investment opportunities.
- It provides a quantitative analysis of market trends from 2021 through 2030 in order to assist stakeholders in maximizing the potential of regenerative medicine markets.
- An extensive analysis of the market, based on services and procedures, helps to understand the trends within the industry.
- We analyze key players and their strategies to determine the competitive outlook for the regenerative medicine industry.
Recent development
- Integra Lifesciences (US), launched AmnioExcel Plus Placental allograft Membrane in February 2020.
- Stryker Corporation purchased Wright Medical in February 2020 to increase its product range
- Smith & Nephew (UK), acquired Osiris Therapeutics, USA (March 2019) in order to expand its product range.
- NuVasive, Inc., announced in September 2018 the commercial launch three new biologics aids to its Propel DBM product line, which includes conventional bone allograft, amniotic Membran DS, as well as additional form factors.
- The Gibco CTS Rotea Counterflow Circulation System was launched by Thermo Fisher Scientific, Inc. in October 2020. This closed-cell therapy processing system allows for the creation and manufacture of cost-effective and scalable cell therapy.
- To expand its product range, Stryker Corporation (US), acquired Wright Medical (US), in November 2019.
Do you have any questions? Consult about the report at: https://market.us/report/regenerative-medicine-market/#inquiry
Key Companies
- DePuy Synthes
- Medtronic
- ZimmerBiomet
- Stryker
- Acelity
- MiMedx Group
- Organogenesis
- UniQure
- Cellular Dynamics International
- Osiris Therapeutics
- Vcanbio
- Gamida Cell
- Golden Meditech
- Cytori
- Celgene
- Vericel Corporation
- Guanhao Biotech
- Mesoblast
- Stemcell Technologies
- Bellicum Pharmaceuticals
Segmentation
Type
- Cell Therapy
- Tissue Engineering
- Biomaterial
Application
- Dermatology
- Cardiovascular
- CNS
- Orthopedic
Frequently Asked Questions About This Report
- What is the size of the market for regenerative medicine?
- How is the market for regenerative medicine growing?
- Which segment had the largest market share in regenerative medicine?
- What are the major players in the regenerative medicines market?
- What are the driving factors for the regenerative medicine industry?
- What are the latest trends in regenerative medicine?
- What are the main players on the market and how fierce is the competition?
- What are the main applications of regenerative medicine products in your life?
- Which region is the most lucrative for the regenerative medicines market?
- Is there a market value for Regenerative Medicine?
- What would the forecast period be in the market report?
- What will be the market value of Regenerative Medicine in 2021?
- Which base year is calculated in theRegenerative medicine market report?
- What are the top companies in the Regenerative Medicine market?
- Which segment is most influential in the Regenerative medicine report?
- What are the top trends in the Regenerative Medicine Market Report?
- What is the growth % and market value of emerging countries?
- What is Regenerative Medicine?
- What is Regenerative MedicineSystems used for?
Explore our related report:
- Global Cell Therapy Market Business Growth based on Expectations and Growth Trends Highlighted Until 2031
- Global Veterinary Software Market Challenges and Opportunities for Stakeholders Focus on Growth Strategies up to 2031
- Automated Cell Culture Market Positive Demand Trends With Different Key Players with Growth Strategies up to 2031
- Global 3D Cell Culture Market Stunning Growth Exhibits Notable Developments And Geographical Outlook up to 2031
- Operating Room Integration Systems Market Opportunities Assessment along with Detailed Analysis and Forecast 2022-2031
- Global Amniotic Membrane Market Competition Scenario focuses on Trends and Innovations during the Period 2022 to 2031
About Market.us
Market.US (Powered by Prudour Private Limited) specializes in in-depth market research and analysis and has been proving its mettle as a consulting and customized market research company, apart from being a much sought-after syndicated market research report providing firm.
Contact Details:
Global Business Development Team – Market.us
Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States
Phone: +1 718 618 4351 (International), Phone: +91 78878 22626 (Asia)
Email: in*****@****et.us